About
Radiopharmaceuticals
Areas of Focus
Categories
Radiopharmaceuticals
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
135
By Phase
EARLY_PHASE1: 1PHASE1/PHASE2: 2
By Status
RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06516510Lead Sponsor
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
EARLY_PHASE1Terminated
17 participants
Started: Oct 31, 2024 · Completed: Aug 15, 2025
NCT06066437Collaborator
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 29, 2024 · Completed: Dec 31, 2027
NCT05413850Lead Sponsor
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
PHASE1/PHASE2Recruiting
82 participants
Started: Jul 20, 2022 · Completed: Mar 31, 2028
Locations (1)
Headquarters
Oxford, UK
Map
Loading map...